sweet kakoii - saved me finding it
So.... they have the IP - worth knowing because Cellspray in terms of product is the rain maker.
ReCell is limited to 2% of the patient's body surface area - so it is for just minor and usually cosmetic surgery.
Cellspray is for up to 90% of the body whilst CellsprayXP is much quicker but covers 30%
Interesting that I scoured every AVH report and never found that 2% max body area anywhere.
Referring to CCE's presentaion:http://www.asx.com.au/asx/statistics/displayAnnouncement.do?display=pdf&idsId=00448809
The applicable global market for ReCell is $1.7billion dollars whilst the Cellspray market is $5billlion
cellspay? cellspray xp?, page-4
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.67 |
Change
0.040(1.52%) |
Mkt cap ! $188.0M | |||
| Open | High | Low | Value | Volume |
| $2.67 | $2.70 | $2.64 | $404.6K | 152.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5532 | $2.64 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.68 | 15319 | 3 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| AVH (ASX) Chart |